FAP and breast cancer: Thus, research conducted on a mouse model of breast cancer showed that the introduction of a catalytically inactive mutant form of FAP into cancer cells does not lead to suppression of inoculated tumor growth, although it is necessary for the proteolytic degradation of ECM [26].